Edition:
India

Rxi Pharmaceuticals Corp (RXII.OQ)

RXII.OQ on NASDAQ Stock Exchange Capital Market

1.20USD
21 Sep 2018
Change (% chg)

$-0.02 (-1.64%)
Prev Close
$1.22
Open
$1.20
Day's High
$1.21
Day's Low
$1.18
Volume
10,091
Avg. Vol
52,102
52-wk High
$7.60
52-wk Low
$1.14

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.06 -0.463
Mar '18 0.02 -0.898
FY 2017 Dec '17 0.01 -0.841
Sep '17 0.00 -1.053
Jun '17 0.00 -1.123
Mar '17 0.00 -2.654
FY 2016 Dec '16 0.00 -6.015
Sep '16 0.00 -3.364
Jun '16 0.01 -3.385
Mar '16 0.01 -3.414
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 0.05 0.05 0.05 --
Quarter Ending Dec-18 1 0.05 0.05 0.05 --
Year Ending Dec-18 1 0.18 0.18 0.18 --
Year Ending Dec-19 1 0.24 0.24 0.24 --
Earnings (per share)
Quarter Ending Sep-18 1 -0.38 -0.38 -0.38 --
Quarter Ending Dec-18 1 -0.35 -0.35 -0.35 --
Year Ending Dec-18 1 -1.88 -1.88 -1.88 --
Year Ending Dec-19 1 -1.23 -1.23 -1.23 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -44.12 -63.75 --
EPS (TTM) % 21.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Rxi Pharmaceuticals Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.63 -6.95 56 --
13 Week -32.02 -35.33 20 --
26 Week -34.64 -39.61 38 --
52 Week -69.83 -74.43 15 --
YTD -28.67 -37.36 45 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 27.16%
# of Holders: 18
Total Shares Held: 1,188,662
3 Mo. Net Change: 997,806
# New Positions: 6
# Closed Positions: 5
# Increased Positions: 9
# Reduced Positions: 8
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.